The FDA And Social Listening For Adverse Effects

As more patients post their medical experiences publicly, could social media be used to shed light on adverse drug and device effects?  To explore this question, thought leaders from the Federal Drug Administration (FDA), industry, pharma, academia and medicine recently gathered to explore collecting and evaluating social media posts to identify adverse effects. Included among them […]

Continue Reading
Social Media Guidance From The FDA

Here is a continuation of an ongoing conversation that I have with Dr. Kevin Campbell. Dr. Campbell is an internationally recognized Cardiologist who specializes in the diagnosis and treatment of heart rhythm disorders. Dr. Campbell is the Medical Expert for WNCN and appears weekly on the NBC17 morning news and also makes frequent appearances nationally […]

Continue Reading
Litigation And eDiscovery For New Communications In Pharma

Pharmaceutical companies are especially susceptible to litigation for false claims, unlawful promotion, drug safety, manufacturing defects, off-label marketing, environmental violations, and illegal distribution. One survey found that respondents from the Life Sciences and Health sector report the highest incidence of at least one lawsuit against their companies (90 percent). While 43 percent of respondents from […]

Continue Reading
Pharmaceutical Company Social Media Policies Best Practices

Originally designed for personal use, social networking sites have proliferated within corporate settings. What started out as a novelty has now evolved to a new channel that is recognized as an effective marketing vehicle. Some companies use social media to promote their products, advertise promotional offers and extend their brand reach. Similarly, companies also use […]

Continue Reading